Chimerix Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Good morning, everyone. This is Andy Singer at Credit Suisse. I want to welcome you to the Credit Suisse Annual Virtual Healthcare Conference. And I'm very pleased to introduce the management team of Chimerix. We have Mike Sherman, the CEO; Mike Andriole and Josh Allen, who is the Chief Technology Officer of Imipridones.
So I'll turn it over to Mike for the presentation.
Great, Andy. I appreciate you having us. It's always nice to present at this conference, it's particularly nice when we have some fresh clinical data -- positive clinical data to be able to share. So I look forward to probably a little bit more focus on that recent news than usual. Here we go. I will be making some forward-looking statements, so please refer to our most recent SEC disclosures for those risks and uncertainties.
I think we'd like to talk about something that we're doing that's unique here at Chimerix,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |